Delivery Order SPE2DB20D2001-SPE2DB25FPNHC
Award Date 7/28/25
Potential Completion Date 7/29/25
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units. This contract, valued at $1,802.80 with a firm fixed price structure, represents a non-set-aside, competitively awarded procurement supporting federal medical supply needs. The order is scheduled for completion by July 29, 2025, and will be fulfilled from the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a $1,145.15 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 30. The contract, which is a firm fixed price delivery order with no set-aside designation, is scheduled for completion by July 28, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This award represents a competitive procurement action and reflects AmerisourceBergen's role as a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Letrozole 2.5mg (90-count supply) valued at $6,490.08 under a firm fixed price contract type. The award was made on July 24, 2025, with an ultimate completion date of the same day, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 units, valued at $1,403.88. This firm fixed price delivery order, which is not set-aside and was competitively awarded, is set for ultimate completion on July 29, 2025. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government, with performance occurring at the...
- This is a $7,898.85 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4568700507 - Letrozole 2.5 mg Tablet 30s. The contract has an ultimate completion date of July 3, 2025 and is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
- This is a $1,705.02 firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 30-count packages of the medication Letrozole 2.5 mg tablets. The contract is not set aside, indicating open competition. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves...
- The Defense Logistics Agency awarded a $32,400 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 90 boxes containing 2.5 mg tablets of Letrozole, an aromatase inhibitor used as a breast cancer treatment. To be performed under contract at Amerisourcebergen's facility located in Conshohocken, Pennsylvania, the order requires delivery by August 28, 2023 to support the DLA's medical supply needs. No subcontractors or set aside designations were indicated. The...
- This federal contract award, valued at $1,219.02, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Letrozole 2.5 mg tablets, a medication used in the treatment of breast cancer. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Letrozole 2.5 mg tablets, a medication used to treat breast cancer. The contract is a firm fixed-price, non-set-aside delivery order with a ceiling value of $2,623.08 and a period of performance through May 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $10,258.50 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 90 tablets of 2.5 mg Letrozole, an aromatase inhibitor used to treat breast cancer. The contract has a period of performance from August 11 to August 14, 2023, with all products to be delivered from the contractor's facility located in Conshohocken, Pennsylvania. No subcontractors or set aside designations were identified. The Defense Logistics Agency...